Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Facondo

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Diagnosis & Prognosis|May 6, 2024
Short-course Radiotherapy for Airway Stenting in Malignant Airway Obstruction: A Case Report and Literature ReviewGiuseppe Facondo, Chiara Reverberi, Tino Ceschia, et al.
Radiation Oncology (London, England)|March 19, 2025
Incidence and predictors of lower extremity lymphedema after postoperative radiotherapy for prostate cancerGiuseppe Facondo, Marta Bottero, Lucia Goanta, et al.
Cancer Treatment and Research Communications|October 26, 2021
Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional studyGiuseppe Facondo, Gianluca Vullo, Maurizio Valeriani, et al.
International Journal of Colorectal Disease|May 12, 2023
Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapyMargherita Rotondi, Giuseppe Facondo, Stefano Mossa, et al.
Journal of Personalized Medicine|February 25, 2023
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological CancersGiuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, et al.
International Journal of Radiation Oncology, Biology, Physics|July 9, 2026
Incidence and Predictors of Fat Necrosis After Single-Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer: Results From a Phase II Clinical TrialGiuseppe Facondo, Agnese Prisco, Chiara Reverberi, et al.
Discover Oncology|November 12, 2024
Long-term outcomes and prognostic factors of short-course radiotherapy (SCRT) in rectal cancer: a monocentric retrospective studyGiuseppe Facondo, Federico Belotti, Margherita Rotondi, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for BrachytherapyGiuseppe Facondo, Gianluca Vullo, Vitaliana DE Sanctis, et al.
Clinical & Experimental Metastasis|October 15, 2021
Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysisCiro Franzese, Luca Nicosia, Giuseppe Facondo, et al.
Frontiers in Oncology|October 11, 2021
Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate CancerMaria Massaro, Giuseppe Facondo, Gianluca Vullo, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Diagnosis & Prognosis|May 6, 2024
Short-course Radiotherapy for Airway Stenting in Malignant Airway Obstruction: A Case Report and Literature ReviewGiuseppe Facondo, Chiara Reverberi, Tino Ceschia, et al.
Radiation Oncology (London, England)|March 19, 2025
Incidence and predictors of lower extremity lymphedema after postoperative radiotherapy for prostate cancerGiuseppe Facondo, Marta Bottero, Lucia Goanta, et al.
Cancer Treatment and Research Communications|October 26, 2021
Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional studyGiuseppe Facondo, Gianluca Vullo, Maurizio Valeriani, et al.
International Journal of Colorectal Disease|May 12, 2023
Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapyMargherita Rotondi, Giuseppe Facondo, Stefano Mossa, et al.
Journal of Personalized Medicine|February 25, 2023
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological CancersGiuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, et al.
International Journal of Radiation Oncology, Biology, Physics|July 9, 2026
Incidence and Predictors of Fat Necrosis After Single-Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer: Results From a Phase II Clinical TrialGiuseppe Facondo, Agnese Prisco, Chiara Reverberi, et al.
Discover Oncology|November 12, 2024
Long-term outcomes and prognostic factors of short-course radiotherapy (SCRT) in rectal cancer: a monocentric retrospective studyGiuseppe Facondo, Federico Belotti, Margherita Rotondi, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for BrachytherapyGiuseppe Facondo, Gianluca Vullo, Vitaliana DE Sanctis, et al.
Clinical & Experimental Metastasis|October 15, 2021
Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysisCiro Franzese, Luca Nicosia, Giuseppe Facondo, et al.
Frontiers in Oncology|October 11, 2021
Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate CancerMaria Massaro, Giuseppe Facondo, Gianluca Vullo, et al.
Pageof 3